Table of Contents

2019-2024 Global Botulinum Toxins Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Botulinum Toxins Consumption 2014-2024
  • 2.1.2 Botulinum Toxins Consumption CAGR by Region
• 2.2 Botulinum Toxins Segment by Type
  • 2.2.1 50U
  • 2.2.2 100U
  • 2.2.3 Other
• 2.3 Botulinum Toxins Consumption by Type
  • 2.3.1 Global Botulinum Toxins Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Botulinum Toxins Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Botulinum Toxins Sale Price by Type (2014-2019)
• 2.4 Botulinum Toxins Segment by Application
  • 2.4.1 Medical
  • 2.4.2 Cosmetic
• 2.5 Botulinum Toxins Consumption by Application
  • 2.5.1 Global Botulinum Toxins Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Botulinum Toxins Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Botulinum Toxins Sale Price by Application (2014-2019)

3 Global Botulinum Toxins by Players

• 3.1 Global Botulinum Toxins Sales Market Share by Players
  • 3.1.1 Global Botulinum Toxins Sales by Players (2017-2019)
  • 3.1.2 Global Botulinum Toxins Sales Market Share by Players (2017-2019)
• 3.2 Global Botulinum Toxins Revenue Market Share by Players
  • 3.2.1 Global Botulinum Toxins Revenue by Players (2017-2019)
  • 3.2.2 Global Botulinum Toxins Revenue Market Share by Players (2017-2019)
• 3.3 Global Botulinum Toxins Sale Price by Players
• 3.4 Global Botulinum Toxins Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Botulinum Toxins Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Botulinum Toxins Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Botulinum Toxins by Regions

• 4.1 Botulinum Toxins by Regions
  • 4.1.1 Global Botulinum Toxins Consumption by Regions
  • 4.1.2 Global Botulinum Toxins Value by Regions
• 4.2 Americas Botulinum Toxins Consumption Growth
• 4.3 APAC Botulinum Toxins Consumption Growth
• 4.4 Europe Botulinum Toxins Consumption Growth
• 4.5 Middle East & Africa Botulinum Toxins Consumption Growth

5 Americas

• 5.1 Americas Botulinum Toxins Consumption by Countries
  • 5.1.1 Americas Botulinum Toxins Consumption by Countries (2014-2019)
  • 5.1.2 Americas Botulinum Toxins Value by Countries (2014-2019)
• 5.2 Americas Botulinum Toxins Consumption by Type
• 5.3 Americas Botulinum Toxins Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Botulinum Toxins Consumption by Countries
  • 6.1.1 APAC Botulinum Toxins Consumption by Countries (2014-2019)
  • 6.1.2 APAC Botulinum Toxins Value by Countries (2014-2019)
• 6.2 APAC Botulinum Toxins Consumption by Type
• 6.3 APAC Botulinum Toxins Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Botulinum Toxins by Countries
  • 7.1.1 Europe Botulinum Toxins Consumption by Countries (2014-2019)
  • 7.1.2 Europe Botulinum Toxins Value by Countries (2014-2019)
• 7.2 Europe Botulinum Toxins Consumption by Type
• 7.3 Europe Botulinum Toxins Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Botulinum Toxins by Countries
  • 8.1.1 Middle East & Africa Botulinum Toxins Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Botulinum Toxins Value by Countries (2014-2019)
• 8.2 Middle East & Africa Botulinum Toxins Consumption by Type
• 8.3 Middle East & Africa Botulinum Toxins Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Botulinum Toxins Distributors
• 10.3 Botulinum Toxins Customer

11 Global Botulinum Toxins Market Forecast

• 11.1 Global Botulinum Toxins Consumption Forecast (2019-2024)
• 11.2 Global Botulinum Toxins Forecast by Regions
  • 11.2.1 Global Botulinum Toxins Forecast by Regions (2019-2024)
  • 11.2.2 Global Botulinum Toxins Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Botulinum Toxins Forecast by Type
• 11.8 Global Botulinum Toxins Forecast by Application

12 Key Players Analysis

• 12.1 Allergan
  • 12.1.1 Company Details
  • 12.1.2 Botulinum Toxins Product Offered
  • 12.1.3 Allergan Botulinum Toxins Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Allergan News
• 12.2 Ipsen
  • 12.2.1 Company Details
  • 12.2.2 Botulinum Toxins Product Offered
  • 12.2.3 Ipsen Botulinum Toxins Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Ipsen News
• 12.3 Merz Pharmaceuticals
  • 12.3.1 Company Details
  • 12.3.2 Botulinum Toxins Product Offered
  • 12.3.3 Merz Pharmaceuticals Botulinum Toxins Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Merz Pharmaceuticals News
• 12.4 Medytox
  • 12.4.1 Company Details
  • 12.4.2 Botulinum Toxins Product Offered
  • 12.4.3 Medytox Botulinum Toxins Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Medytox News
• 12.5 US World Meds
  • 12.5.1 Company Details
  • 12.5.2 Botulinum Toxins Product Offered
  • 12.5.3 US World Meds Botulinum Toxins Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 US World Meds News
• 12.6 LIBP
  • 12.6.1 Company Details
  • 12.6.2 Botulinum Toxins Product Offered
  • 12.6.3 LIBP Botulinum Toxins Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 LIBP News

...

13 Research Findings and Conclusion

Botulinum toxin (BTX) is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species. It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction and thus causes flaccid paralysis. Infection with the bacterium causes the disease botulism. The toxin is also used commercially in medicine, cosmetics and research.
In the last several years, global market of Botulinum Toxins developed rapidly, with an average growth rate of 14.6%. In 2017, global revenue of Botulinum Toxins is nearly 4000 million USD; the actual production is about 12.4 million units.
The classification of Botulinum Toxins includes 50U, 100U and other, and the sales proportion of 50U in 2017 is about 59.3%. Botulinum Toxins is used for medical and cosmetic. Medical was the largest application segment in 2017, the proportion is about 51%.

According to this study, over the next five years the Botulinum Toxins market will register a 13.3% CAGR in terms of revenue, the global market size will reach US$ 8500 million by 2024, from US$ 4550 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Botulinum Toxins business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Botulinum Toxins market by product type, application, key manufacturers and key regions and countries.

This study considers the Botulinum Toxins value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
50U
100U
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Medical
Cosmetic

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Allergan
Ipsen
Merz Pharmaceuticals
Medytox
US World Meds
LIBP
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Botulinum Toxins consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Botulinum Toxins market by identifying its various subsegments.
Focuses on the key global Botulinum Toxins manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Botulinum Toxins with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Botulinum Toxins submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.